B · Normal
[Prime Editing "Rewrites" DNA in the Human Body for the First Time] On October 26, according to a report on the British "Nature" website on the 22nd, the American biotechnology company Prime Medicine announced that it has used Prime Editing technology to directly edit DNA in the human body for the first time to treat a patient with Wilson's disease. The first clinical trial results are expected to be announced in 2027.
Global market intelligence 🕐 2026-10-26 07:06
#clinical trial #Biotechnology #DNA #Global market intelligence
Save as Image Generate a beautiful long image to share on Moments or in group chats Generate now ⬇
← Back to Telegraph

Related telegraphs

On October 26, Canadian Imperial Bank of Commerce lowered the target price of Ai 10-26 12:20 On October 26, Indonesia's benchmark stock index fell 1.7% to 5,349.754 points. 10-26 11:07 [Lula: Brazil is “no one’s backyard” and will strengthen regulation of technolog 10-26 10:47 [The shadow of AI burning money is looming, and it is difficult for technology g 10-26 10:01 [Brazilian market may be about to plummet, Lula's unexpected victory is expected 10-26 09:59 On October 26, the Philippine peso fell to a record low against the U.S. dollar, 10-26 09:57

Comments

0/500
Captcha (click to refresh)
No comments yet